Skip to main content

Year: 2023

Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Phase 1 dose escalation for VIP943 – first antibody-drug conjugate (ADC) from VersAptx™, versatile and adaptable, next-generation bioconjugation platform – moves quickly into 2nd cohort Phase 1 dose escalation for VIP236 – first-in-class small molecule-drug conjugate (SMDC) for treatment of solid tumors – progressing well with optimized dosing schedule Phase 1 dose escalation combination study for enitociclib in collaboration with NIH – partial response in first patient dosed in second cohort Cash balance expected to support planned operations into late 2024 PALO ALTO, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC)(“Vincerx”), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics,...

Continue reading

Form 8.3 – DX (GROUP) PLC – 13 11 2023 – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree DX (GROUP) PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Global Bitumen Market Size Worth USD 170.14 Billion in 2032 | Emergen Research

The global Bitumen Market size is expected to reach USD 170.14 Billion in 2032 registering a CAGR of 5.0% Discover the latest trends and analysis on the Bitumen Market Vancouver, Nov. 14, 2023 (GLOBE NEWSWIRE) — The global bitumen market, valued at USD 170.14 Billion in 2022, is poised to experience a steady revenue Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period. Key factors propelling this growth include the increasing demand for Polymer-Modified Bitumen (PMB) in the construction industry, a surge in global road construction activities, and a rising need for bitumen in the roofing sector. Polymer-Modified Bitumen (PMB) is gaining popularity in various construction applications due to its exceptional qualities, including stability, durability, and resistance to deformation. Governments worldwide are investing...

Continue reading

Global Metal Casting Market Size to Reach USD 312.74 Billion in 2032 | Emergen Research

The global Metal Casting Market size is expected to reach USD 312.74 Billion in 2032 registering a CAGR of 7.7% Discover the latest trends and analysis on the Metal Casting Market Vancouver, Nov. 14, 2023 (GLOBE NEWSWIRE) — The global metal casting market exhibited a robust performance in 2032, reaching a valuation of USD 312.74 Billion. Anticipated to maintain a substantial growth trajectory, the market is expected to register a revenue CAGR of 7.7% during the forecast period. Key factors influencing this growth include the rising demand from the automotive and construction industries, the increasing adoption of 3D printing, and the stringent emission and fuel efficiency guidelines. Metal casting, a process involving pouring molten metal into shaped molds, finds extensive applications in high-tech industries such as transportation,...

Continue reading

Castellum, Inc. Announces Third Quarter Financial Results

Castellum, Inc. Announces Third Quarter Financial ResultsThird Quarter 2023 Financial Highlights•Revenues were $11.7 million. •Gross profit was $4.8 million. •Operating loss, inclusive of all non-cash and non-recurring charges, including a $6.9 million write-down of goodwill triggered by the Company’s stock price, was $8.6 million.•Non-GAAP Recurring Cash Operating Profit was positive $194.7 thousand. https://castellumus.com/BETHESDA, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) — Castellum, Inc. (the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces highlights of its operating results for its third quarter ended September 30, 2023. Third Quarter 2023 Financial HighlightsRevenues were $11.7 million. Gross profit was...

Continue reading

Interim Management Statement covering Q1 2023/24

Interim Management Statement covering Q1 2023/24 The Board of Directors of Rovsing A/S has today reviewed and approved the Interim Management Statement for the first quarter (1 July 2023– 30 September 2023) of the financial year 2023/24. Q1 highlightsThe Q1 2023/24 revenues and EBITDA are in line with expectations.In Q1 of the financial year 2023/24, the revenue amounted to DKK 8,1 million (DKK 5,5 million in Q1 2022/23), which is an increase of 47%.Q1 EBITDA amounts to DKK 0,6 million (DKK 0,0 million in Q1 2022/23).The Company maintains a high order backlog of DKK 62,1 million at the end of Q1. On this basis, Rovsing has a positive operational outlook and growth opportunities for the coming years as industry opportunities continue a positive trend. In order to execute the order backlog the Company has and will continue to scale...

Continue reading

Macrogol Polyethylene Glycol Market Size Worth USD 8.98 Billion in 2032 | Emergen Research

Macrogol/PEG Market Set for Substantial Growth Driven by Increasing Demand in Pharmaceuticals and Chemical Industries Vancouver, Nov. 14, 2023 (GLOBE NEWSWIRE) — The global macrogol/Polyethylene Glycol (PEG) market size was USD 4.90 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.3% during the forecast period. The global macrogol/PEG market is poised for substantial growth, driven by a surge in demand for PEG in drugs, medicinal devices, and chemical applications. Market research indicates that key factors influencing this growth include the adoption of PEG derivatives in various industries, such as pharmaceuticals, cosmetics, and food products, as well as the rising use of PEG in cancer therapy technologies. The market is characterized by polyether compounds like PEG 200, PEG 400, PEG 600, PEG 1000, PEG 3350,...

Continue reading

DHS Makes Full Acquisition of Carolco Enterprises for $745M: Fernando Aguirre, Vice Chairman of DHS Ventures & Holdings Announced

WASHINGTON, Nov. 14, 2023 (GLOBE NEWSWIRE) — The leadership of DHS Ventures & Holdings announced today that it will acquire Carolco Enterprises from AXIS Capital, the merchant banking arm of Merrill Lynch. The financial value of the deal was not disclosed but an Economic Times report pegs it at $745 million. DHS Ventures & Holdings has bought all rights through its associates Bellinger & Sons, Thai Company Limited along with ISK Investment, a DHS Ventures group company. Carolco Enterprises, which the DHS Ventures & Holdings regards as a core business, is part of the defunct Carolco Pictures that went under in 1975. Carolco was an American independent motion picture production company that existed from 1976 to 1995, founded by Mario Kassar and Andrew G. Vajna. Kassar and Vajna ran Carolco together until 1989....

Continue reading

Teleflex to Present at the 35th Annual Piper Sandler Healthcare Conference

WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 35th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Tuesday, November 28, 2023 at 11:30 a.m. (ET). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia,...

Continue reading

Freight Technologies, Inc. Announces Strong Q3 Preliminary Earnings

Results include 27% Annualized Revenue Growth and 27% Year-over-Year YTD Margin Increase HOUSTON, Nov. 14, 2023 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT), a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, today unveils its preliminary financial results for Q3 2023. Key Financial Highlights: 27% Quarter-over-Quarter Annualized Revenue Growth: Based on preliminary numbers, the company achieved strong revenue growth in the third quarter of 2023, with a noteworthy 27.2% annualized increase (6.8% sequential) compared to the previous quarter and 55.4% annualized growth compared to the first quarter of 2023. This growth highlights...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.